The five-year funding commitment represents a 5 percent increase over the previous grant period for the rapidly growing archive of 3D protein structures.
The German company's new Genome Enhancer product is an adaptation of its flagship multi-omics software for clinicians and biologists without bioinformatics expertise.
A New York Genome Consortium-led team plans retrospective and prospective analyses on very rare cancers in the hopes of improving treatment options available for patients.
In Nucleic Acids Research: software for analyzing transcriptomic and proteomic data, Fido-SNP tool for predicting consequences of SNVs in the dog genome, and more.
Cancer Moonshot-funded teams are profiling pre-cancers in an effort to establish targeted treatment, detection, and prevention methods that can be applied before cancers form.
Michigan-based Advaita Bioinformatics wants to be a one-stop shop for proteomics, transcriptomics, and variant analysis, as well as internet omics search.
